Showing results (41-50 of 128) with videos related to
Sort By:
Pageof 13
Expert Opinion on Pharmacotherapy|August 19, 2017
Novel combination strategies for enhancing efficacy of immune checkpoint inhibitors in the treatment of metastatic solid malignanciesMichael J Flynn, James M G LarkinJournal of Biomedical Optics|January 7, 2017
Mapping optical path length and image enhancement using quantitative orientation-independent differential interference contrast microscopyMichael Shribak, Kieran G Larkin, David BiggsBritish Journal of Cancer|February 3, 2011
Challenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapiesM E Gore, J M G LarkinBritish Journal of Hospital Medicine|October 1, 1990
Disorders of ocular motilityG Larkin, J Elston, P G BainExpert Opinion on Investigational Drugs|May 31, 2006
Epothilones in the treatment of cancerJames M G Larkin, Stanley B KayeBritish Journal of Haematology|July 21, 2005
Mice are unsuitable for modelling ABO discordance despite strain-specific A cross-reactive natural IgMJames M G Larkin, Colin D PorterCancer Immunology, Immunotherapy : CII|May 23, 2006
Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapyJames M G Larkin, Colin D PorterJournal of Cataract and Refractive Surgery|April 29, 1998
Relationship between intraocular lens biomaterials and posterior capsule opacificationP G Ursell, D J Spalton, M V Pande, et al.American Journal of Ophthalmology|June 14, 2000
Posterior capsular opacification with hydrogel, polymethylmethacrylate, and silicone intraocular lenses: two-year results of a randomized prospective trialE J Hollick, D J Spalton, P G Ursell, et al.AORN Journal|October 31, 2012
Translating evidence to practice for mechanical venous thromboembolism prophylaxisBrenda G Larkin, Kimberly M Mitchell, Kathryn PetriePageof 13